GlaxoSmithKline is adding new Veeva Commercial Cloud applications as part of its ongoing program for customer engagement globally. In addition to further expanding Veeva CRM into more regions, GSK will deploy Veeva Network, Veeva Align, and Veeva CRM Approved Email to execute its multichannel strategy in more than 90 countries.
 
“We’ve seen tremendous progress with Veeva CRM in delivering more informed, tailored interactions with our customers across many touch points and channels,” said Daniel Lebeau, chief information officer and head of core business services at GSK.
 
GSK has deployed Veeva CRM in more than half of their global target countries, with expansion continuing into other countries, including the U.S.
 
GSK will also use the Veeva Network to provide a complete view of customer data, Veeva Align to align the right resources to the right customers, and Veeva CRM Approved Email for customer teams to extend their reach.
 
“We’re proud to have contributed to GSK’s success and we’re excited for the expanded opportunity to support their global efforts,” said Peter Gassner, founder and chief executive officer of Veeva Systems. “Veeva Commercial Cloud will give GSK teams full visibility into customer interactions so that they can deliver the right information tailored to their customers’ needs, when they need it, and in the channels that they prefer.”